NASDAQ:CCXI

52.00
0.00 (0.00%) 1d
0
DON'T BUY
ChemoCentryx
A biotech with shares that more than doubled on a single day on a takeover bid by Biogen. At best, you'll make over a dollar per share if the deal goes ahead. If not, you will lose a fortune. Avoid.
biotechnology
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

ChemoCentryx(CCXI-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for ChemoCentryx is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

ChemoCentryx(CCXI-Q) Frequently Asked Questions

What is ChemoCentryx stock symbol?

ChemoCentryx is a American stock, trading under the symbol CCXI-Q on the NASDAQ (CCXI). It is usually referred to as NASDAQ:CCXI or CCXI-Q

Is ChemoCentryx a buy or a sell?

In the last year, there was no coverage of ChemoCentryx published on Stockchase.

Is ChemoCentryx a good investment or a top pick?

ChemoCentryx was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for ChemoCentryx.

Why is ChemoCentryx stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is ChemoCentryx worth watching?

In the last year, there was no coverage of ChemoCentryx published on Stockchase.

What is ChemoCentryx stock price?

On 2022-10-19, ChemoCentryx (CCXI-Q) stock closed at a price of $52.